Home / breast

breast

October 15, 2025

Contrast-enhanced mammography in screening and symptomatic work

Contrast-enhanced mammography (CEM) is an advanced breast imaging technique that enhances traditional mammography with iodine-based contrast, offering both structural and functional insights. It significantly improves cancer detection, especially in women with dense breast tissue, where conventional mammography often falls short. CEM demonstrates high sensitivity and specificity, rivalling breast MRI in many diagnostic scenarios, including pre-operative […]

Dr Vasiliki Papalouka

Barts Health NHS Trust, London

Read Article

June 23, 2025

Breast screening and health inequalities: one screening service’s experience of addressing health inequalities

Breast screening services have always had a responsibility to encourage breast screening attendance. It has become evident that health inequalities influence both screening uptake and cancer treatment pathways. Activity within services to increase breast screening attendance therefore needs to understand and address health inequalities. To access the full article as a pdf please sign up […]

Claire Bailey

St George's University Hospitals NHS Foundation Trust

Read Article

June 23, 2025

Factors that impact radiography advanced practitioners’ diagnostic efficacy

Breast cancer is the most commonly diagnosed cancer in the UK, with around 41,000 cases reported annually. Early detection is paramount, with nine out of 10 women surviving for at least five years when the cancer is caught in its early stages. The NHS Breast Screening Programme (NHSBSP) plays a critical role in improving survival […]

Noelle Clerkin

Belfast Health and Social Care Trust

Read Article

January 16, 2025

Double reporting with arbitration in the symptomatic setting – is it worth it?

National breast screening and high risk screening mammograms in the UK are all double reported with arbitration. However, with regard to symptomatic mammogram reporting, the guidance does not stipulate that double reporting is required, which allows for variation in practice based on departmental protocols. Our service also double reported all non-breast screening mammograms, including symptomatic […]

Laura Sewell, Dr Kirsty McNeil, Dr Sarah Savarides

NHS Tayside, University of Dundee

Read Article

April 17, 2024

Experience of mammography AI in a UK screening centre

AI applications in the field of breast imaging have gained a great deal of interest. Despite the use of computer-aided detection in breast screening having been studied in the past, it was not until the last decade that developments in machine learning and processing power made it possible to apply AI to digital imaging and […]

Dr Gerald Lip, Sarah Philip, Michelle Cumming, Lana Fairburn

North East Scotland Breast Screening Centre

Read Article

February 14, 2024

Second-look ultrasound after MRI

The use of MRI to stage breast cancer and its use as a screening tool in the very high risk (VHR) screening cohort have increased hugely over the past 15 years. This has been driven partly by the increasing range of breast conserving surgical techniques that are available. Recalling patients back to ultrasound for further […]

Dr Tamara Suaris

St Bartholomew's Hospital, Queen Mary University of London

Read Article

February 14, 2024

Wire-free localisation techniques for impalpable breast lesions

The mainstay of treatment for most breast cancers is breast conserving surgery. Impalpable breast lesions usually require image-guided localisation in advance of surgery, which facilitates the surgeon in identifying the target intraoperatively, allowing the area of disease to be excised with clear margins, while also ensuring that excess normal tissue is not removed. In this […]

Dr Simon Lowes

Gateshead Health NHS Foundation Trust

Read Article

January 17, 2024

Exploring whether FAST MRI could detect aggressive breast cancers earlier than mammography

Breast cancer is the most common cancer in the UK. Delays to breast cancer surgery as short as four weeks cost lives because treatments are effective and early detection improves survival. Early detection also makes it less likely that a mastectomy or chemotherapy are needed. The NHS population-risk screening programme offers women aged 50-70 a […]